These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 23711888)
41. A monoclonal antibody derived by inoculation of human umbilical vein endothelial cells is a potential inhibitor of acetylcholine receptor-linked vasorelaxation. Jung SH; Ryu Y; Lee D; Park SB; Lee KJ; Lee HM; Kim J; Kim B; Won KJ Gen Physiol Biophys; 2019 Nov; 38(6):505-512. PubMed ID: 31588917 [TBL] [Abstract][Full Text] [Related]
42. Effect of training frequency on endothelium-dependent vasorelaxation in rats. Heylen E; Guerrero F; Mansourati J; Theron M; Thioub S; Saïag B Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):52-8. PubMed ID: 18277186 [TBL] [Abstract][Full Text] [Related]
44. Vasodilatory effects of cholinergic agonists are greatly diminished in aorta from M3R-/- mice. Khurana S; Chacon I; Xie G; Yamada M; Wess J; Raufman JP; Kennedy RH Eur J Pharmacol; 2004 Jun; 493(1-3):127-32. PubMed ID: 15189773 [TBL] [Abstract][Full Text] [Related]
45. Monoclonal antibody against α-actinin 4 from human umbilical vein endothelial cells inhibits endothelium-dependent vasorelaxation. Won KJ; Lee KP; Kim DK; Jung SH; Lee CK; Lee DH; Yu SY; Park SH; Lee HM; Kim B J Vasc Res; 2013; 50(3):210-20. PubMed ID: 23711888 [TBL] [Abstract][Full Text] [Related]